Dapavo, Paolo, Matteo Megna, and Marina Talamonti. “Efficacy of Tildrakizumab 200 Mg for Treating Difficult-to-Treat Patient Populations With Moderate to Severe Plaque Psoriasis”. Dermatology Reports (August 9, 2024). Accessed December 4, 2024. https://www.pagepress.org/journals/dr/article/view/9999.